title: Review of the effectiveness of capsaicin for painful cutaneous disorders and neural dysfunction.
abstract: BACKGROUND
  Topical capsaicin is known to be a safe and effective pain management adjunct for rheumatoid arthritis, osteoarthritis, neuralgias, and diabetic neuropathy. However, studies and case reports in the literature have indicated that other conditions may also benefit from capsaicin: painful or itching cutaneous disorders from operations, injuries, or tumors; neural dysfunction; or inflammation of the airways and urinary tract.
  
  
  METHODS
  To determine the effectiveness of capsaicin for painful cutaneous disorders and neural dysfunction, the authors analyzed data from 33 reports (MEDLINE search of 1966-96) on the efficacy of capsaicin. Outcome measures consisted of the response rate and degree of pain relief. Results from placebo-controlled trials were pooled when possible; effect of treatment was estimated by the method of DerSimonian and Laird.
  
  
  RESULTS
  Pain relief for postmastectomy syndrome and cluster headache was greater with capsaicin than with placebo; also, psoriasis and pruritus responded better to capsaicin. Uncontrolled studies and case reports have indicated that pain or dysfunction was less at the end of capsaicin therapy for neck pain, loin pain/hematuria syndrome, oral mucositis, rhinopathy, reflex sympathetic dystrophy syndrome, detrusor hyperreflexia, and cutaneous pain due to tumor of the skin.
  
  
  CONCLUSIONS
  Capsaicin is effective for psoriasis, pruritus, and cluster headache; it is often helpful for the itching and pain of postmastectomy pain syndrome, oral mucositis, cutaneous allergy, loin pain/hematuria syndrome, neck pain, amputation stump pain, and skin tumor; and it may be beneficial for neural dysfunction (detrusor hyperreflexia, reflex sympathetic dystrophy, and rhinopathy). A universal problem for many of the studies analyzed was the absence of a "burning placebo" such as camphor.
authors.affiliation: Department of Anesthesia and Critical Care, the University of Chicago, Illinois 60637, USA.
authors.forename: M
authors.initials: M
authors.lastname: Hautkappe
authors.forename: M F
authors.initials: MF
authors.lastname: Roizen
authors.forename: A
authors.initials: A
authors.lastname: Toledano
authors.forename: S
authors.initials: S
authors.lastname: Roth
authors.forename: J A
authors.initials: JA
authors.lastname: Jeffries
authors.forename: A M
authors.initials: AM
authors.lastname: Ostermeier
mesh_terms: D002211:Capsaicin / Q000627:therapeutic use*; D006801:Humans; D009422:Nervous System Diseases / Q000188:drug therapy* / Q000503:physiopathology*; D010146:Pain / Q000188:drug therapy* / Q000503:physiopathology; D012871:Skin Diseases / Q000188:drug therapy* / Q000503:physiopathology*
chemical_list: D002211:Capsaicin